IL140163A0 - Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome comprising propionyl-l-carnitine and genistine - Google Patents

Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome comprising propionyl-l-carnitine and genistine

Info

Publication number
IL140163A0
IL140163A0 IL14016399A IL14016399A IL140163A0 IL 140163 A0 IL140163 A0 IL 140163A0 IL 14016399 A IL14016399 A IL 14016399A IL 14016399 A IL14016399 A IL 14016399A IL 140163 A0 IL140163 A0 IL 140163A0
Authority
IL
Israel
Prior art keywords
genistine
carnitine
propionyl
osteoporosis
prevention
Prior art date
Application number
IL14016399A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of IL140163A0 publication Critical patent/IL140163A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL14016399A 1998-06-23 1999-06-17 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome comprising propionyl-l-carnitine and genistine IL140163A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000417A IT1299191B1 (it) 1998-06-23 1998-06-23 Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
PCT/IT1999/000174 WO1999066913A2 (en) 1998-06-23 1999-06-17 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein

Publications (1)

Publication Number Publication Date
IL140163A0 true IL140163A0 (en) 2002-02-10

Family

ID=11406005

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14016399A IL140163A0 (en) 1998-06-23 1999-06-17 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome comprising propionyl-l-carnitine and genistine

Country Status (27)

Country Link
US (1) US6335038B1 (de)
EP (1) EP1089742B1 (de)
JP (1) JP4430233B2 (de)
KR (1) KR20010071541A (de)
CN (1) CN1306434A (de)
AR (1) AR018924A1 (de)
AT (1) ATE228367T1 (de)
AU (1) AU755272B2 (de)
BR (1) BR9911440A (de)
CA (1) CA2334875C (de)
DE (1) DE69904172T2 (de)
DK (1) DK1089742T3 (de)
EE (1) EE200000741A (de)
ES (1) ES2188177T3 (de)
HU (1) HU224957B1 (de)
IL (1) IL140163A0 (de)
IS (1) IS5764A (de)
IT (1) IT1299191B1 (de)
MA (1) MA26655A1 (de)
NO (1) NO20006431L (de)
NZ (1) NZ508877A (de)
PL (1) PL192118B1 (de)
PT (1) PT1089742E (de)
SK (1) SK19292000A3 (de)
TN (1) TNSN99132A1 (de)
TR (1) TR200003735T2 (de)
WO (1) WO1999066913A2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
US6476010B2 (en) * 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
WO2001070212A2 (en) * 2000-03-23 2001-09-27 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of menopause
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
IT1317079B1 (it) 2000-12-21 2003-05-26 Sigma Tau Ind Farmaceuti Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
ES2289097T3 (es) * 2001-03-15 2008-02-01 Dsm Ip Assets B.V. Composicion para la prevencion de la osteoporosis consistente de una combinacion de isoflavonas y acidos grasos poliinsaturados.
AUPR957001A0 (en) * 2001-12-19 2002-01-24 Novogen Research Pty Ltd Isoflavone conjugates, derivatives thereof and therapeutic methods involving same
US20050090457A1 (en) * 2002-02-15 2005-04-28 N.V. Nutricia Method of treating mammals with genistein and/or genistein analogues
KR100542478B1 (ko) * 2002-08-28 2006-01-11 한경대학교 산학협력단 석류 유래 피토에스트로겐을 함유하는 건강기능식품
AU2003294667A1 (en) * 2002-09-09 2004-04-08 Nestec S.A. Orally administrable composition for improving skin quality
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
EP1633208A1 (de) * 2003-05-27 2006-03-15 DSM IP Assets B.V. Neue diätetische zusammensetzungen und deren verwendung
JP2005187454A (ja) * 2003-12-05 2005-07-14 Sankyo Co Ltd ビタミンｅ含有ｌｄｌ低下剤及び／又は動脈硬化抑制剤組成物
KR20060132667A (ko) * 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물
US7666913B2 (en) * 2004-02-03 2010-02-23 Kotosugi Inc. Method of treating or preventing osteoporosis using isotaxiresinol derived from Taxus yunnanensis
DE602005022431D1 (de) * 2004-03-17 2010-09-02 Nestec Sa Zusammensetzungen und verfahren zur reduzierung oder vorbeugung von fettleibigkeit
CN100351248C (zh) * 2004-07-05 2007-11-28 南京大学 染料木素衍生物及其制法和用途
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
AU2005322015B2 (en) 2004-12-29 2010-02-25 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
AU2005323934A1 (en) * 2005-01-10 2006-07-13 Hormos Medical Ltd The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency
JP5112308B2 (ja) * 2005-07-08 2013-01-09 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ 角膜疾患の治療のための食餌サプリメントまたは医薬の調製のためのｌ−カルニチンまたはアルカノイルｌ−カルニチン、脂溶性ベンゾキノンおよびオメガ−３−多価不飽和脂肪酸を含む組合せの使用
JP5284087B2 (ja) 2005-07-14 2013-09-11 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物の生命を延長するための方法
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
KR20080068850A (ko) * 2005-10-14 2008-07-24 디에스엠 아이피 어셋츠 비.브이. 레스베라트롤을 포함하는 기능성식품 조성물의 신규한 용도
BRPI0618222A2 (pt) * 2005-11-02 2011-08-23 Nestec Sa composições de isoflavona para reduzir o acúmulo de gordura corporal em animais machos, e métodos para seu uso
WO2007099432A2 (en) 2006-02-28 2007-09-07 Council Of Scientific And Industrial Research Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof
JP5227195B2 (ja) * 2006-02-28 2013-07-03 ネステク ソシエテ アノニム 骨成長の誘発及び骨損失の抑制のための組成物及び方法
WO2007116052A1 (en) * 2006-04-12 2007-10-18 Unilever Plc Oral composition comprising dha and genistein for enhancing skin properties
MX2008012998A (es) * 2006-04-12 2008-10-17 Unilever Nv Composicion oral con efecto anti-envejecimiento en la piel.
US8987329B2 (en) * 2006-04-12 2015-03-24 Conopco, Inc. Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
US20080108696A1 (en) * 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
BRPI0918134B1 (pt) 2008-09-10 2019-02-12 Kaken Pharmaceutical Co., Ltd Derivado de prostaglandina i2
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
WO2010054978A1 (en) * 2008-11-11 2010-05-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
KR101158856B1 (ko) 2009-05-12 2012-06-25 한국생명공학연구원 콩잎 추출물 또는 이의 분획물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 조성물
BR112012022632B1 (pt) * 2010-03-08 2020-03-31 Kaken Pharmaceutical Co., Ltd. Medicamento compreendendo Agonista de ep4
EP2582368B1 (de) * 2010-06-16 2018-05-09 Alfasigma S.p.A. Acetyl-L-carnitin zur Erhöhung der Neurogenese in neuronalem Gewebe
WO2012011572A1 (ja) * 2010-07-23 2012-01-26 国立大学法人大阪大学 拡張不全型心不全治療薬
IT201700116392A1 (it) * 2018-04-03 2019-10-03 Composizione per somministrazione orale aventi benefico effetto sulla salute della donna in menopausa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases

Also Published As

Publication number Publication date
NZ508877A (en) 2002-09-27
AU755272B2 (en) 2002-12-05
CA2334875A1 (en) 1999-12-29
TNSN99132A1 (fr) 2005-11-10
HUP0102879A3 (en) 2002-12-28
PT1089742E (pt) 2003-04-30
ITRM980417A0 (it) 1998-06-23
TR200003735T2 (tr) 2001-03-21
US6335038B1 (en) 2002-01-01
JP4430233B2 (ja) 2010-03-10
CN1306434A (zh) 2001-08-01
HU224957B1 (en) 2006-04-28
WO1999066913A2 (en) 1999-12-29
NO20006431D0 (no) 2000-12-15
AU4390999A (en) 2000-01-10
PL192118B1 (pl) 2006-09-29
CA2334875C (en) 2009-05-12
SK19292000A3 (sk) 2001-08-06
AR018924A1 (es) 2001-12-12
JP2002518437A (ja) 2002-06-25
WO1999066913A3 (en) 2000-04-20
BR9911440A (pt) 2001-03-20
EE200000741A (et) 2002-04-15
NO20006431L (no) 2001-02-22
ES2188177T3 (es) 2003-06-16
ITRM980417A1 (it) 1999-12-23
EP1089742B1 (de) 2002-11-27
ATE228367T1 (de) 2002-12-15
IS5764A (is) 2000-12-08
PL345030A1 (en) 2001-11-19
IT1299191B1 (it) 2000-02-29
EP1089742A2 (de) 2001-04-11
MA26655A1 (fr) 2004-12-20
DE69904172T2 (de) 2003-08-28
DE69904172D1 (de) 2003-01-09
HUP0102879A2 (hu) 2002-03-28
KR20010071541A (ko) 2001-07-28
DK1089742T3 (da) 2003-03-24

Similar Documents

Publication Publication Date Title
IL140163A0 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome comprising propionyl-l-carnitine and genistine
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
HUP0103920A2 (hu) Eljárás és kompozíció vérszegénység kezelésére és megelőzésére
HUP0201409A3 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
IL143921A0 (en) Compositions for the treatment and prevention of tumors and tumor-related disorders
EP0979074A4 (de) Behandlung oder vorbeugung klimakteriumsymptomen und der osteoporose
HUP0302492A3 (en) Methods and compositions for the prevention of tolerance to medications
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
EP1119255A4 (de) Neue zusammensetzungen und verfahren zur vorbeugung und behandlung von protozoenerkrankungen
GB9706842D0 (en) Pharmaceutical compositions for the treatment of rhinitis
IL138247A (en) Substituted bisindolymaleimides for the inhibition of cell proliferation and pharmaceutical compositions comprising them
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
HUP0003679A3 (en) Use of pkc inhibitors for the preparation of pharmaceutical compositions treating cardiovascular diseases
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
HRP980097A2 (en) Combinatory compositions for the treatment of dementia
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
HK1041826B (zh) 治療或預防肌肉廢用綜合症的口服肌酸化合物
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
EP1305017A4 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von syndrom x
SI1083887T1 (sl) Farmacevtski sestavki za zdravljenje ulkusov